Psoriasis Archives - MPR

Psoriasis

Scalp Psoriasis Study Data Added to Otezla Labeling

The labeling for Otezla (apremilast; Amgen) has been updated to include safety and efficacy information related to the treatment of patients with moderate to severe plaque psoriasis of the scalp. The STYLE trial was a double-blind, placebo-controlled study that included 303 patients with moderate to severe plaque psoriasis of the scalp who had a Scalp…

Certain Blister Packages of Sandimmune, Neoral Not Child Resistant

Certain blister packages of Sandimmune (cyclosporine capsules) and Neoral (cyclosporine capsules) may not meet child-resistant packaging requirements, according to manufacturer Novartis.  The Company announced that it is working with the Consumer Product Safety Commission to address the packaging issue. In a press statement, Novartis stressed that there are no quality or efficacy issues with the…